Wave Life Sciences reviews

Thank you for taking the time to provide your feedback. We are happy to hear that you value our benefits strategy and available snacks. We are excited about the continued advancement of our Huntington’s disease programs in the clinic, as well as the initiation of two additional CNS clinical programs in the second half of 2020. Further we believe that the continued evolution of our PRISM discovery and drug development platform will yield new opportunities to make a difference in the lives of countless rare disease patients and their families.

At Wave, we are excited about the continued advancement of our Huntington’s disease programs in the clinic, as well as the initiation of two additional CNS clinical programs in the second half of 2020. Further we believe that the continued evolution of our PRISM discovery and drug development platform will yield new opportunities to make a difference in the lives of countless rare disease patients and their families.